Feline squamous cell carcinoma: Difference between revisions
imported>Howard C. Berkowitz (New page: {{subpages}} <!-- Text is transcluded from the BASEPAGENAME/Definition subpage-->) |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
< | {{TOC|right}} | ||
Among the most common malignant cancers of cats, '''feline squamous cell carcinoma''' has a wide range of survival expectations and treatments. The [[neoplasm]] tends not to produce distant metastases, but is highly invasive, and, especially in the mouth cavity, can interfere with quality of life. | |||
Early diagnosis is key. A biopsy is likely to be needed, possibly aspirational but preferably incisional. If in the oral cavity, a high index of suspicion for infection should be kept and appropriate antibiotic therapy used aggressively. | |||
==Treatment== | |||
===Specific tumor reduction=== | |||
Assuming the owner authorizes active treatment, the first steps are radiation or radiation coupled with chemotherapy, followed by additional cycles of chemotherapy and possibly additional radiation. One series using these methods, with bleomycin or carboplatin after fractionated electron beam radiotherapy, had survivals from 11 to over 400 days, with a median of 90. Other protocols have substantially extended life. <ref>{{citation | |||
| A retrospective study of <sub>90<sub>Strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum | |||
| author= Mark Goodfellow ''et al.'' | |||
| journal = Journal of Feline Medicine & Surgery | |||
| volume=8 | issue=3 | date = June 2006 |pages=169-176 | |||
|doi= 10.1016/j.jfms.2005.12.003}}</ref> | |||
Some of the tumors express [[cyclooxygenase-2]], so a selective [[NSAID]] offers both pain relief and the potential to reduce the inflammation of a tumor. Unfortunately, these agents also can cause life-threatening gastrointestinal bleeding. It is not yet standard practice to administer them with a prophylactic [[proton pump inhibitor]] or [[histamine H2 antagonist]]. | |||
===Quality of life=== | |||
Pain management is a challenge in cats, due to their intolerance of many [[opioid analgesic]]s. [[Gabapentin]], orally or by a skin-absorptive gel, can provide baseline pain relief. Buprenorphine, orally, in the buccal cavity, or subcutaneously is useful for breakthrough pain. | |||
==References== | |||
{{reflist|2}} | |||
Revision as of 03:55, 20 June 2010
Among the most common malignant cancers of cats, feline squamous cell carcinoma has a wide range of survival expectations and treatments. The neoplasm tends not to produce distant metastases, but is highly invasive, and, especially in the mouth cavity, can interfere with quality of life.
Early diagnosis is key. A biopsy is likely to be needed, possibly aspirational but preferably incisional. If in the oral cavity, a high index of suspicion for infection should be kept and appropriate antibiotic therapy used aggressively.
Treatment
Specific tumor reduction
Assuming the owner authorizes active treatment, the first steps are radiation or radiation coupled with chemotherapy, followed by additional cycles of chemotherapy and possibly additional radiation. One series using these methods, with bleomycin or carboplatin after fractionated electron beam radiotherapy, had survivals from 11 to over 400 days, with a median of 90. Other protocols have substantially extended life. [1]
Some of the tumors express cyclooxygenase-2, so a selective NSAID offers both pain relief and the potential to reduce the inflammation of a tumor. Unfortunately, these agents also can cause life-threatening gastrointestinal bleeding. It is not yet standard practice to administer them with a prophylactic proton pump inhibitor or histamine H2 antagonist.
Quality of life
Pain management is a challenge in cats, due to their intolerance of many opioid analgesics. Gabapentin, orally or by a skin-absorptive gel, can provide baseline pain relief. Buprenorphine, orally, in the buccal cavity, or subcutaneously is useful for breakthrough pain.
References
- ↑ Mark Goodfellow et al. (June 2006), Journal of Feline Medicine & Surgery 8 (3): 169-176, DOI:10.1016/j.jfms.2005.12.003